List of Microbiome Companies in California - 47

Aardvark Therapeutics is a clinical stage biopharmaceutical company focused on leveraging host adaptive responses through gut-brain signaling for the treatment of metabolic and inflammatory diseases. The company has multiple programs in its pipeline and has received FDA orphan drug designation for its novel drug candidate for Prader-Willi syndrome.

Harvesting the power of Nature, Allied Microbiota develops advanced microbes to clean-up environmental contamination faster, more sustainably, and more cost-effectively than traditional remediation methods. Our products tackle the toughest contaminants like those from manufactured gas plants, chlorinated organics, and even emerging contaminants like per- and poly-fluoroalkyl substances (PFAS). We developed a heat-loving microbe called ThermO+ that breaks down contaminants at a fraction of the cost and significantly faster than traditional methods. Powered by heat and on oxygen, our microbes can clean difficult contaminants such as chlorinated compounds like polychlorinated biphenyls (PCBs), petroleum products, and dioxins from the soil, turning brownfields into greenfields. We don't bury the problem. We solve it. Site cleans ups can be expensive, but our technology makes this possible for companies, developers, and communities. We aim and strive to create cleaner, healthier, and productive areas around the world. Make Allied Microbiota your fast, affordable, and go-to solution for a cleaner tomorrow.

Since 2016, AnimalBiome has helped tens of thousands of pet parents and veterinarians monitor and improve the gut health, and overall health, of companion animals around the world. See how we can help your pet or veterinary practice at animalbiome.com or animalbiome.vet (veterinarians only).

Apton is a California-based biotechnology company that manufactures and supplies single-molecule detection and sequencing imaging systems for clinical applications.

Ardigen is a bioinformatics company that specializes in AI-driven solutions for drug discovery and precision medicine.

Armata Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for the treatment of antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company’s product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for the treatment of Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing proprietary synthetic phage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.

Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutic candidates to treat disorders associated with the microbiome. It is involved in the development of core inhibitors that inhibit the functional activities of HBV core protein at various points in the viral lifecycle.

BioForm Solutions is a San Diego-based contract research organization providing services for the analysis of probiotics in the supplement, food and beverage, cosmetic, and agriculture markets. BioForm Solutions offers industry leading, cutting edge flow cytometry assays developed exclusively by the BioForm team. These assays offer a broad spectrum of solutions for the analysis of probiotic samples in most formulations and are supported by a dedicated staff having over 20 years experience in flow cytometry. We strive to improve our customer's probiotic-based products, including accurately enumerating the viability of probiotics, determining packaging effects, and shelf life evaluation. We are passionate about providing the highest quality services at an outstanding value, along with superior customer service and technical support.

Biolumen is a weight-loss and gut health company, on a mission to reverse the negative impact of the Western diet; like obesity, type 2 diabetes and autoimmune disorders. Biolumen's product, Monch Monch, is a highly functional cellulose matrix which entraps calories in the stomach.

Biopico Systems Inc is a leader in the emerging field of interacting multiple organ systems or microphysiological systems technology. This technology will accurately recapitulate human physiology by engineering physiological fluidic flow and organ microenvironment.

Bloom Science is a clinical-stage, central nervous system (CNS) company, trailblazing a path to transformative, novel therapeutics for patients with rare and complex neurological disorders. Bloom’s proprietary discovery platform, IrisRx™ enables a fundamentally different approach to developing medicines by harnessing our expanding insight into the Gut-Brain Axis to design and develop therapeutics that target novel biology with superior safety profiles. The IrisRx™ platform unlocks the potential for developing multi-functional therapeutics from the most common cell type in the human body, gut commensal microbes, while also utilizing an expanding proprietary knowledge base to advance therapeutic candidates based on synthetic biology. Bloom Science is advancing a deep pipeline of programs in Dravet syndrome; other rare epilepsies; Amyotrophic Lateral Sclerosis (ALS), a disease that causes nerve cells to die, which breaks the neural pathways, and causes extreme mobility loss over time; and neurodegenerative and cognitive disorders.

Clarity Genomics provides consulting services for microbiome-metabolome data insights in clinical research. Using our global network of specialists and regional cloud storage and computing, we provide expertise in collection and preparation of microbiome and metabolome samples, data processing and analysis. We work closely with our clients to offer biological insights that empower the development of new microbiome products and therapies. Partnerships with leading research institutions ensure that your project receives relevant information utilizing technologies and techniques on the forefront of innovation.

DERMALA, Inc. is a pioneering consumer dermatology startup leveraging the power of the human microbiome and cutting-edge data analytics to develop innovative, patented, science-backed, and clinically validated solutions for a range of skin conditions including acne, eczema, and skin health & longevity.

We are the first gut microbiome, genetics-based virtual care platform for people struggling with polychronic mental & physical illness associated with weight and gut. We use AI to harness clinical, genetic, gut microbiome, food and behavioral signals to target the root cause of illness. We deliver tailored whole-person care, including remote monitoring, food-as-medicine, pharma reduction, behavioral coaching support, and care coordination. We use AI to harness food information, clinical, genetic, gut microbiome, and behavioral signals, to deliver tailored holistic care, including food as medicine, behavioral coaching support, remote monitoring, and care coordination, to target the root cause of illness. Our customers love us because we acknowledge their unique physiology, lifestyle, food habits and deliver data-driven personalized care supported by specialist coaches that puts the customer in charge.

We are a skincare startup founded in 2018 in San Francisco. We combat the rise of skin conditions and sensitive skin by building a world in which beauty and science work together to produce optimal health. We develop clean, science-backed products that respect our skin's natural ecosystem. Discover our B2B microbiome tech platform @hellobiome. Our founder, Elsa Jungman, has a Ph.D. with strong expertise in dermatology, microbiome and clean beauty. She is a UCSF, L'Oréal and AOBiome alumna.

Endure Biotherapeutics (“Endure Bio” ™) in San Diego, California, was founded by Professor Amir Zarrinpar MD, PhD, at the Zarrinpar Laboratory, UCSD. The company is developing engineered engraftable live biotherapeutics for gastrointestinal diseases by genetically engineering man’s native bacteria to express therapeutic compounds (such as anti-inflammatory cytokines). Unlike other GI focused microbiome companies, our biotherapeutics will be targeted to remain resident, delivering potentially curative solutions that endure the host environment.

Flightpath Biosciences - We are scientists committed to advancing new therapies targeting pathogen-driven diseases Flightpath Biosciences uses advanced drug discovery tools to identify optimal antimicrobial therapeutic candidates to vastly improve drug targeting and safety, reduce off-target impacts on the microbiome, speed the time-to-market and reduce the risk of antibiotic resistance. In parallel, our data science and bioinformatics partners are working hard to understand host and microbiome genetics and transcriptomics to further define the impact of our drugs on the patient’s immune system, microbiome and overall health. We believe this will lead us to new data, novel discoveries and additional targeted therapeutic candidates.

Infinant Health, Inc is a privately held company committed to changing the trajectory of human health, one baby at a time, through our deep understanding of infant nutrition and the gut microbiome. Years of proprietary research into the role of breast milk and its impact on human development led to our groundbreaking discovery of B. infantis EVC001, a natural bacterial strain foundational to infant immune health. Unfortunately, B. infantis had been almost completely eradicated from infants in developed countries due to unintended consequences of modern medicine such as feeding and birthing practices. Now, there is a way to change that. What we found is that EVC001, our specific strain of B. infantis, is essential in developing a healthy microbiome and supporting healthy immune system function. We took that learning and developed INF108, a next-generation strain developed to prevent necrotizing enterocolitis (NEC) in pre-term infants. We believe the greatest chance to impact future health begins early, right after birth—a once in a lifetime opportunity where rapid development and radical changes occur. By unlocking human nutrition's full potential through introducing beneficial bacteria during early infancy, we can help build a foundation for better health. Investors in Infinant Health include Cargill and Bill & Melinda Gates Foundation, among others.

Founded by Jennifer Doudna, the Innovative Genomics Institute advances genome engineering to cure disease and ensure food security.

At Intrinsyx Bio, we are commercializing 3 decades of the leading academic research in the plant microbiome. Our endophytic microbes cause crop plants, grasses, ornamental plants, and trees to fix Nitrogen (N2) directly from the atmosphere into ammonia which helps improve nutrient use efficiency, supplement synthetic fertilizer requirements, and increase chlorophyll. These microbes live in leaves, stems, roots and don't require a nodule. Our endophyte microbes also mobilize insoluble phosphorous (P2) from soil into roots, as well as increase drought and salt tolerances.

Jarrow Formulas is a California-based formulator and supplier of nutritional supplement products including vitamins, minerals, probiotics, concentrates, and enzymes.

Jumpcode Genomics is changing the way scientists see their samples with our proprietary CRISPRclean® technology. Combining CRISPR-based technology and next-generation sequencing (NGS) they can now search for and find novel signals they previously couldn't. Our technology removes unwanted sequences, allowing researchers worldwide to extract greater insights. By increasing sensitivity and allowing access to a range of sample types, we're broadening the understanding of human biology in fields from research to clinical applications including infectious disease and oncology.

Koliber Biosciences is a biotechnology company that accelerates biomedical discoveries using machine learning and artificial intelligence.

MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company focused on the $142 Billion WW dermatology and skin care market. We are developing therapies for the top 5 dermatology & skin care conditions - Atopic Dermatitis, Rosacea, Psoriasis, Acne, and Skin Infections, which have a huge impact on quality of life. More than 230 million patients suffer from these 5 skin diseases, which represent a $12.9 Billion Rx market and a $121 Billion skin care market.

Mawi's innovative non-invasive and invasive biosample collection technologies are designed for room temperature transport and storage with OMICS in mind ... Less Sample, More Answers! Our Mission is to offer simple and easy to use tools for the collection and stabilization of an array of biological samples from the point of collection to processing in Genomics, Proteomics and metabolomics assays, including but not limited to: -Oral samples (e.g. buccal cells) -Whole Blood -Tissue - Mammalian Cells -Body fluids -Microbial samples from different sources (e.g. feces, urine, vaginal, skin, soil etc....) Mawi DNA Technologies' vision is to uphold sample integrity from anywhere in the world with innovative technology that promotes sample collection diversity.

For over 60 years, MeriCal has provided custom manufacturing and packaging services to the dietary supplement industry. Our state-of-the-art facilities located in Southern California and Ogden, UT offer a wide range of capabilities from research and development to turn-key manufactured & packaged products. MeriCal offers innovative nutritional products for today's world. We have over 230 years of combined industry experience on our team, along with a world-class formulation team you can trust. We globally source clinically researched ingredients to custom formulate unique solutions that meet our customer's needs. Today, we are a leading manufacturer and packaging leader in the dietary supplement industry. MeriCal offers extensive knowledge in the formulation and manufacturing of gummies, tablets, capsules, chewables, and powders for any size business or brand. From simple contract work to developing market-driven solutions, MeriCal does it all. Our goal is to exceed our customer's expectations in every endeavor. MeriCal embraces the core values of team work, respect, honesty and courtesy. As part of our ongoing commitment to providing a positive and healthy work environment for all of our employees, MeriCal offers a wide variety of employee benefits, including medical, dental and vision insurance, life insurance, holiday pay, PTO and a 401(K) retirement plan.

Gene editing is changing the world. Founded by pioneers in the CRISPR/CAS revolution, Metagenomi is discovering the next generation of gene-editing systems for use in treating genetic diseases.

NorthStrive Biosciences Inc., a PMGC Holdings company, is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Our lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.

We make seriously sweet proteins that are changing the world, one bite at a time. Sweetness from protein—not sugar—is the breakthrough you’ve been waiting for. They’re good for your body and good for the planet, but it’s their amazing taste that will keep you coming back. The gut-friendly, diabetic-friendly, all flavor, no compromise win we all deserve. We’re a team of biologists, engineers, food-lovers, health advocates and environmentalists on a mission to transform the world with healthy sweetness. Come join us in building a sweeter future for all. Try our NEW Lemonade: 80% less sugar, no alternative sweeteners, & made with real fruit!🍋🍓

Osel’s mission is to develop and commercialize a broad portfolio of Live Biotherapeutic Products (LBPs) that prevent or treat abnormal conditions resulting from a disruption of the human microbiome. In 2003, Osel was one of the first companies to receive FDA authorization to test a live bacterial therapeutic, and is a pioneer in the field of LBPs. Our proprietary approach identifies differences between healthy and disease-related microbiomes, and leverages beneficial microbes to treat problematic disruptions or ‘dysbioses’. Osel’s approach of repopulating the microbiome with beneficial bacteria helps restore healthy and protective microbiomes. The primary focus of our work is women’s health, with indications including recurrent urinary tract infections and bacterial vaginosis. Our secondary focus is disorders of the gastrointestinal tract. Our product pipeline is demonstrating exciting therapeutic potential, with two clinical stage products and ongoing clinical trials.

Pando Nutrition is a company in the livestock production industry that develops next generation probiotics to accelerate the transition towards antibiotic-free production, fighting disease, enhancing growth, and improving nutrition for animals.

Parallel is a next-generation skin health company providing effective, targeted solutions powered by microbiome science, genomics, and machine learning. At Parallel, everything we do is grounded in science and innovation. We believe that the future is precision medicine and we believe that what we’re building is vital to that vision. Here, consumers and patients can access best-in-class expertise and clinical guidance, a personalized genomic assessment to understand their skin microbiome, as well as personalized, targeted microbiome skincare products and prescriptions (if needed). With one of the largest data sets in the world on the skin microbiome, a 10,000-deep bacterial library, and patents pending, Parallel was just honored by Fast Company as a "World Changing Idea."

Persephone is pioneering the use of synthetic biology for microbial products that impact patient and infant health. We are building an end-to-end platform to industrialize the development of engineered cells that restore health to damaged human ecosystems. The company was founded in the summer of 2017 by synthetic and metabolic engineering pioneers, Stephanie Culler PhD, and Steve Van Dien PhD.

Phyla is a clinically-proven acne probiotic that uses breakthrough technology to only kill bad acne bacteria on your skin so your microbiome can flourish.

One of CNBC's 20 Hottest Startups of 2014, ProdermIQ is a personalized skin care startup delivering the first objective skin health measurement tool to the commercial, research and medical markets. ProdermIQ capitalizes on the convergence of personalized medicine, probiotic health benefits and next generation genetic analysis technologies to create a consumer-accessible testing and analytical platform with unsurpassed sensitivity and accuracy at detecting and characterizing the skin microbiome. The ProdermIQ SKINdex Skin Health Measurement tool provides consumers and skin health professionals with current skin health status as well as information that may improve or maintain a healthy skin environment. Our mission is to is to create healthy and beautiful skin by first understanding the underlying environment on the skin and then driving the development of the next generation of personalized skin care by empowering individuals and skin health professionals. Our vision of bringing personalized skincare to professionals and consumers has earned us the title of one of the top 50 innovative companies for 2014 by the Global Entrepreneurs Week - http://startupopen.com/gew50/

Pylum is engineeringbacteriocinsand pyocins to target a variety ofpathogenicbacteria including E. coli, and K pneumoniae.Pyocins are similar to phage tail-like protein complexes and have bactericidal activity against strains ofPseudomonas.

Siolta Therapeutics is a clinical-stage biotech company developing live biotherapeutics to improve outcomes in conditions with unmet medical needs. Our offices and laboratory are located in San Carlos, CA.

We are improving how we farm and what we eat by unleashing the natural power that exists in plants to create a more agile and resilient agriculture system.

The microbiome is the new frontier gut health and changes to your microbiome signature is now being understood as a central conduit of health and disease. IBD, IBS, Crohn's, colitis, type I diabetes, arthritis, metabolic syndrome, and several autoimmune disorders have all been associated with microbiome changes also known as dysbiosis. When you total the number of individuals affected by these diseases, over 80% Americans suffer from dysbiosis annually. With this much science there still aren't real solutions for dysbiosis. And since dysbiosis is the result of changes to the 1000's different microbes of our gut it is nearly impossible to find the right remedy for your specific dysbiosis. Sun Genomics is empowering the consumer to educate themselves about their microbiome signature and make informed, as well as transparent, product selections to manage their dysbiosis. We are helping consumers realize the power of their microbiota through genomics, probiotics, microbiology, informatics, and software.

Taxa Technologies is a probiotics company that aims to revolutionize the understanding of microbiome engineering. They are focused on designing probiotics for personal care and enabling cheaper, faster, and better genetic engineering.

Trace Genomics is a pioneer in the use of hi-definition genomics to activate the hidden insights in soil for healthier soils and a healthier planet. Through innovation in genomics, soil science and machine learning, Trace Genomics creates a pathway to deliver targeted database insights and actions at cost-speed-scale-accuracy for partners who are advancing modern farming solutions for a net-zero food production system. Where most companies deliver a partial picture, we provide a comprehensive and precise understanding of the soil’s composition—analyzing the soil’s biology, physical properties and chemistry. Trace Genomics has won several awards, including being selected as a 2020 Technology Pioneer by the World Economic Forum, Winner of FoodShot Global’s Innovating Soil 3.0 Challenge, Forbes Top 25 Most Innovative AgTech, THRIVE Top 50 AgTech, 2022 Global Cleantech top 100 start-ups and many more.

Turn Therapeutics® is a concept to approval pharmaceutical and medical device organization dedicated to reducing the human and economic costs of infection and skin disease. Turn Therapeutics® was founded with a goal of reducing antibiotic resistance through best in class acute and chronic wound care products. Through research and development, we have continued to uncover additional disease areas that our technology will serve. Our core mission is to leverage our expertise in drug delivery to create disruptive products for high need indications.

Viomeanalyzes your microbiome and uses artificial intelligence to process the results and provide dietary advice.

Xeno Biosciences is pioneering a novel class of treatments targeting the human gut microbiome to address unmet needs in metabolic diseases.

Yakult is the world's leading probiotic beverage created in Japan in 1935. It is produced by Yakult Honsha Co., Ltd - the world's pioneer in probiotics. Today, Yakult is sold in more than 30 countries and regions around the world. Our company's portfolio includes a range of consumer, cosmetic and pharmaceutical products. For additional company information, please visit www.yakult.co.jp/english/. Science and research are the basis of our business. We have institutes in both Japan and Europe that are committed to discovering the endless applications for probiotics as well as the use of intestinal bacteria in human health globally. For more information about our science institutes, please visit www.yakult.co.jp/institute. Bringing Yakult to America is just one more step towards fulfilling Yakult's mission: to contribute to the health and happiness of every person around the world through the pursuit of excellence in life sciences and the study of microorganisms. We hope to achieve this goal while providing education to people about healthier living, developing community programs where we do business, and collaborating with medical doctors, dietitians and researchers. Yakult U.S.A. Inc. is a subsidiary of Yakult Honsha Co., Ltd. and is headquartered in Fountain Valley, CA. It supports Yakult's business in the United States and Canada. To contact our offices please email yakult@yakultusa.com.

ZBiotics is a synthetic biology company founded in 2016 and headquartered in San Francisco, California. The company bioengineers probiotic bacteria to create innovative products such as ZBiotics® Pre-Alcohol, a probiotic drink that breaks down the byproduct of alcohol responsible for negative effects.

Since its inception in 1994, Zymo Research has been proudly serving the scientific community by providing innovative, reliable, and high quality research tools at affordable prices. Our vision..."The Beauty of Science is to Make Things Simple"​ is now truer than ever. Whether it's epigenetics, DNA, RNA, E. coli, or yeast based research, our philosophy remains the same: To provide the highest quality products in the industry while ensuring they are both simple to use and reliable in their performance. Zymo Research is historically recognized for its innovation of high quality nucleic acid purification technologies. Under the branding DNA Purification Made Simple™ and RNA Purification Made Simple™, our technologies are pushing the limits of what is possible with nucleic acid isolation. As The Epigenetics Company™, Zymo Research has also received much attention for its rapidly expanding portfolio of epigenetics products and services. It is our objective to develop and provide the most comprehensive set of tools for DNA, RNA, and epigenetic research and analysis available today. Thousands of peer-reviewed scientific publications from researchers around the world feature our technologies. Through innovation, our scientists have made streamlined DNA methylation detection possible, pioneered the micro-elution column for DNA and RNA purification, developed the simplest and the most sophisticated methods for high-quality plasmid DNA purification, and patented the first RNA purification directly from Trizol without phase separation among many other leading technologies in the industry. At Zymo Research, we are committed to quality and guarantee that all of our products and service will meet and exceed your expectations. We pledge to be honest and responsible for everything we do with you. We will treat you as we would like to be treated. Together, we will build a brighter future.